Levonorgestrel-releasing intrauterine system: uses and controversies

@article{Bahamondes2008LevonorgestrelreleasingIS,
  title={Levonorgestrel-releasing intrauterine system: uses and controversies},
  author={Luis Bahamondes and Maria V Bahamondes and Ilza Maria Urbano Monteiro},
  journal={Expert Review of Medical Devices},
  year={2008},
  volume={5},
  pages={437 - 445}
}
This article provides a perspective on the use of the levonorgestrel-releasing intrauterine system as a contraceptive method and as therapy in different situations, as well as presenting the corresponding controversies and unresolved issues. All studies have reported high contraceptive efficacy, an improvement in menstrual blood loss in women with idiopathic menorrhagia, menorrhagia due to thrombophilic diseases and fibroids, and excellent endometrial protection during postmenopausal estrogen… Expand
Review Article Levonorgestrel Intrauterine System Mirena : An Update
TLDR
Mirena is one of the most effective forms of contraception available, and combines the advantages of both hormonal and intrauterine contraception, and gives the users many non-contraceptive benefits: the amount of menstrual bleeding and the number of days of menstruation are reduced, which makes it suitable for the treatment of menorrhagia. Expand
Levonorgestrel Intrauterine System Mirena: An Update
TLDR
This review article tries to explore different aspects of Mirena for treatment of menorrhagia compared to other available methods based on recent trials. Expand
Added health benefits of the levonorgestrel contraceptive intrauterine system and other hormonal contraceptive delivery systems.
BACKGROUND It has been recognized for well over half a century that hormonal preparations designed as contraceptives are also capable of offering health benefits through the treatment and preventionExpand
Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis.
TLDR
It seems that LNG-IUS demonstrates significant and comparable improvements in hemoglobin levels to hysterectomy in treating adenomyosis-associated menorrhagia during the first year. Expand
Progestins and medical treatment of endometriosis – Physiology, history and society
  • J. Bélaisch
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2009
TLDR
Arguments in favour of continuous administration of hormones are developed to obtain not simply an anovulation but a state of prolonged amenorrhea much more efficacious than the simple suppression of ovulation too often advised in endometriosis. Expand
Levonorgestrel-releasing IUD versus copper IUD in control of dysmenorrhea, satisfaction and quality of life in women using IUD
TLDR
There is no difference between these two groups in terms of the satisfaction and quality of life, therefor the usage of Mirena IUD is not a preferred contraception method. Expand
The LNG-IUS: The First Choice Alternative to Hysterectomy? Intrauterine Levonorgestrel-Releasing Systems for Effective Treatment and Contraception
TLDR
It is the most commonly performed gynaecological surgical procedure although the incidence of hysterectomy varies widely across the world, and such rates being highest in the industrialized world has led to the major controversy that hySterectomies are being largely performed for unwarranted and unnecessary reasons. Expand
Body weight and composition in users of levonorgestrel-releasing intrauterine system.
TLDR
An increase in mean fat mass among LNG-IUS users at 12 months of use was observed and an increase of body weight was also observed in both groups after 1 year of insertion of the device, however, a study with a larger number of women and long-term evaluation is necessary to evaluate these body changes. Expand
Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system.
TLDR
BMD at the midshaft of the ulna and ultra-distal radius in LNG-IUS users were similar to that of IUD users and remained unchanged between the 7th and the 10th years of use. Expand
Birth Control and Family Planning Using Intrauterine Devices (IUDs)
TLDR
The medical techniques for inserting and removing a IUD, and the role of US to confirm proper IUD placement are presented and practical guidance in managing problems of continuing users is offered. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 122 REFERENCES
The levonorgestrel intrauterine system for use in peri- and postmenopausal women.
The intrauterine system (IUS) delivering levonorgestrel (LNG; Mirena), initially developed as a long-acting method of contraception, has demonstrated its efficacy and safety in a large number ofExpand
Progestin-releasing intrauterine systems and leiomyoma.
TLDR
Findings indicate that insertion of a LNG-IUS represents an appropriate therapeutic option for selected women with menstrual symptoms associated with uterine fibroids, and Clinicians who candidly inform patients regarding what the authors do and do not know regarding the benefits and risks should selectively make this therapy available prior to resorting to surgical therapies. Expand
The levonorgestrel intrauterine system: therapeutic aspects
TLDR
The third major indication for therapeutic use is in protection of the endometrium in estrogen replacement therapy during peri- and postmenopausal years, and acceptance and continuation of use of the LNG IUS in hormone replacement therapy (HRT) have been high. Expand
The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders.
TLDR
The LNG-IUS should be considered when managing menorrhagia because surgery carries additional risks in this subset of patients. Expand
Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
TLDR
In conclusion, LNG-IUS was an effective treatment for three out of four women with menorrhagia and could be an alternative treatment for women withMenorrhAGia who are either contraindicated for or refuse hysterectomy or endometrial ablation. Expand
Levonorgestrel‐releasing intrauterine device in the treatment of menorrhagia
TLDR
The Lng‐IUCD seems to be an important alternative to oral medication and to hysterectomy in the treatment of menorrhagia and there was a significant increase in serum ferritin during the first year of Lng-IUCD use. Expand
A Latin American experience with levonorgestrel IUD.
TLDR
The levonorgestrel releasing IUD (LNg IUD) is the first device which is at the same time highly effective, long-lasting and reduces the blood loss during menstruation and will have a clear niche among reversible contraceptives, when available. Expand
Long-term experience of a levonorgestrel-releasing intrauterine system.
  • V. Odlind
  • Medicine
  • The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
  • 1996
The levonorgestrel-releasing intrauterine system is a highly effective, long-acting, safe and reversible method of contraception, which offers additional health effects through its effects onExpand
The levonorgestrel-releasing intrauterine device.
  • J. Toivonen
  • Medicine
  • Advances in contraceptive delivery systems : CDS
  • 1994
TLDR
Levonorgestrel generally has an effect on the ovaries just during the 1st year of use, which causes scanty and thick cervical mucus, its major contraceptive mode of action. Expand
Therapeutic use of the LNG IUS, and counseling.
TLDR
Use of LNG-releasing intrauterine system (LNG IUS) in treatment and prevention of anemia and in the therapy of menorrhagia and dysmenorrhea and the antiproliferative effect of the LNG I US on the endometrium is discussed. Expand
...
1
2
3
4
5
...